How fast will I lose weight on GLP-1s and is it sustainable?

GLP-1 medications are powerful tools for weight loss, but it's important to have realistic expectations about speed and sustainability.

How Fast Will You Lose Weight?

Weight loss on GLP-1s is typically gradual and steady, not rapid, and varies significantly from person to person.

• Average Loss: Clinical trials for Wegovy (semaglutide) and Zepbound (tirzepatide) showed participants losing, on average, between 15% and 22.5% of their starting body weight over 68 to 72 weeks (about 1.5 years), when combined with lifestyle changes.
• Timeline:
  • Initial Weeks/Months: You might notice a more noticeable drop initially as your body adjusts and appetite significantly decreases. Many people report losing a few pounds per week.
  • Ongoing: The rate of loss tends to slow down over time, but generally continues for as long as you're taking the medication and adhering to a healthy lifestyle.
  • Titration: GLP-1s are typically started at a low dose and gradually increased over several weeks or months to minimize side effects. This means the most significant weight loss often doesn't begin until you're on a higher, more therapeutic dose.
• Factors Influencing Speed:
  • Starting Weight: Individuals with more weight to lose may see a larger initial drop.
  • Dietary Changes: These medications help control appetite, but a consistent calorie deficit from healthy food choices is still crucial.
  • Physical Activity: Regular exercise significantly enhances weight loss and overall health benefits.
  • Individual Response: Everyone's body reacts differently to the medication.
  • Type of Medication: Zepbound (tirzepatide) has generally shown slightly higher average weight loss in trials compared to Wegovy (semaglutide).

Is It Sustainable?

Yes, but with important caveats. The sustainability of weight loss on GLP-1s largely depends on continued use of the medication and a commitment to lifestyle changes.

• Mechanism of Action: These medications work by mimicking natural hormones that regulate appetite, satiety, and blood sugar. When you stop taking them, those hormonal effects diminish, and your body's natural hunger signals and metabolic drives often return to their baseline.
• Long-Term Treatment: For most individuals, GLP-1s are considered a long-term or even lifelong treatment for chronic weight management, similar to how someone with high blood pressure might take medication indefinitely. Stopping the medication often leads to weight regain.
• Lifestyle Integration is Key:
  • Sustainable Eating Habits: While the medication helps suppress appetite, it's vital to use this opportunity to learn and embed healthy eating patterns. Focus on nutrient-dense foods, portion control, and mindful eating.
  • Regular Exercise: Physical activity helps maintain muscle mass, boost metabolism, and improve overall health, making weight maintenance easier.
  • Behavioral Changes: Addressing underlying psychological factors related to eating (e.g., emotional eating, stress) is critical for long-term success.
• Medical Supervision: Sustainable weight management on GLP-1s requires ongoing medical supervision to monitor effectiveness, manage side effects, and make adjustments as needed.
• Cost and Access: The high cost of these medications and insurance coverage can be a barrier to long-term sustainability for some.

Specific Brand Recommendations for Weight Loss:

• Wegovy (semaglutide): This is the first FDA-approved GLP-1 medication specifically for chronic weight management in adults who are overweight or obese and do not have type 2 diabetes. It's administered once weekly via injection.
• Zepbound (tirzepatide): This is a newer, FDA-approved medication for chronic weight management that acts on two incretin hormones (GLP-1 and GIP). Clinical trials have shown it can lead to even greater weight loss than semaglutide. It's also administered once weekly via injection.

Important Note: While medications like Ozempic (semaglutide) and Mounjaro (tirzepatide) are approved for Type 2 Diabetes and often result in significant weight loss, Wegovy and Zepbound are the specific formulations and dosages FDA-approved for weight management in non-diabetic individuals.

In summary, GLP-1s offer a highly effective path to weight loss that can be sustainable if you commit to long-term medication use, integrate healthy lifestyle changes, and maintain ongoing medical supervision. It's crucial to discuss these options with a healthcare provider to determine if they are right for you.